
亚太荧光免疫分析市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品类型(ELISA、快速侧流免疫分析等)、应用(传染病、肿瘤学、心血管疾病等)和最终用户(医院和诊所、诊断中心、制药和生物技术公司、学术和研究机构等)
No. of Pages: 167 | Report Code: BMIRE00025659 | Category: Life Sciences
No. of Pages: 167 | Report Code: BMIRE00025659 | Category: Life Sciences
亚太地区荧光免疫分析市场预计将从2021年的5.0391亿美元增长到2028年的8.111亿美元;预计2021年至2028年复合年增长率为7.0%。
荧光染料或荧光团已被广泛用作探针(用于物理和结构参数)、指示剂(例如,用于分子浓度)或各种生物测定中的标记/示踪剂(例如,用于生物分子的可视化和定位)。因此,荧光染料的开发以及适当的设备及其应用对医疗保健行业产生了重大影响。新技术、材料和设备已经被开发出来,可以有效地检测和利用生物样品中的荧光信号。对灵敏且廉价的诊断工具的需求催生了增强诊断测定的荧光信号的新策略,包括改善生物分子的表面固定、增加每个结合事件的荧光标记的密度以及改善荧光报告基因的光学特性。增强荧光性能的一种方法是开发具有改进的亮度、光稳定性、量子产率和斯托克斯位移的荧光染料。荧光标记也已用于通过各种技术创建均质免疫测定。异硫氰酸荧光素 (FITC) 是一种有机荧光染料,可能是免疫荧光和流式细胞术中最常用的染料之一。它可以利用其反应性异硫氰酸酯基团与各种抗体偶联,异硫氰酸酯基团可与蛋白质的氨基、巯基、咪唑基、酪氨酰基或羰基结合。 FITC 是最早用于荧光显微镜的染料之一,也是其他荧光染料的前体。其荧光活性归因于其广泛的共轭芳香族电子系统,该系统被蓝光光谱激发。因此,由于荧光染料和仪器的发展不断加快,荧光免疫分析市场预计在未来几年将会增长。
凭借新的功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动亚太地区荧光免疫分析市场实现显着的复合年增长率。
2028 年亚太地区荧光免疫分析市场收入及预测(百万美元)
亚太地区荧光免疫分析市场细分
亚太地区荧光免疫分析市场分为产品类型、应用、最终用户和国家。根据产品类型,市场分为 ELISA、快速侧流免疫分析等。 ELISA 领域在 2021 年占据市场主导地位,预计在预测期内增长最快。根据应用,市场分为传染病、肿瘤、心血管疾病等。传染病领域在 2021 年占据市场主导地位,预计在预测期内增长最快。根据最终用户,市场分为医院和医疗机构。诊所、诊断中心、制药和医疗中心生物技术公司、学术界和研究机构等。医院和诊所领域在 2021 年占据市场主导地位,预计在预测期内增长最快。按国家/地区划分,亚太地区荧光免疫分析市场分为中国、日本、印度、韩国、澳大利亚和亚太地区其他地区。
雅培、BD、bioMerieux SA、丹纳赫、F. Hoffmann-La Roche Ltd.、Ortho Clinical Diagnostics Holdings plc、Quidel Corporation、西门子AG、Sysmex Corporation 和 Thermo Fisher Scientific Inc. 是亚太地区荧光免疫分析市场的领先公司之一。
Strategic insights for Asia-Pacific Fluorescent Immunoassay involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 503.91 Million |
Market Size by 2028 | US$ 811.10 Million |
Global CAGR (2021 - 2028) | 7.0% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品类型
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia-Pacific Fluorescent Immunoassay refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia-Pacific Fluorescent Immunoassay Market is valued at US$ 503.91 Million in 2021, it is projected to reach US$ 811.10 Million by 2028.
As per our report Asia-Pacific Fluorescent Immunoassay Market, the market size is valued at US$ 503.91 Million in 2021, projecting it to reach US$ 811.10 Million by 2028. This translates to a CAGR of approximately 7.0% during the forecast period.
The Asia-Pacific Fluorescent Immunoassay Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia-Pacific Fluorescent Immunoassay Market report:
The Asia-Pacific Fluorescent Immunoassay Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia-Pacific Fluorescent Immunoassay Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia-Pacific Fluorescent Immunoassay Market value chain can benefit from the information contained in a comprehensive market report.